J. B. Chemicals & Pharmaceuticals Gestione
Gestione criteri di controllo 2/4
J. B. Chemicals & Pharmaceuticals Il CEO è Nikhil Chopra, nominato in Dec2020, e ha un mandato di 3.92 anni. la retribuzione annua totale è ₹ 71.34M, composta da 49.2% di stipendio e 50.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.026% delle azioni della società, per un valore di ₹ 69.90M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.8 anni e 4.1 anni.
Informazioni chiave
Nikhil Chopra
Amministratore delegato
₹71.3m
Compenso totale
| Percentuale dello stipendio del CEO | 49.2% |
| Mandato del CEO | 3.9yrs |
| Proprietà del CEO | 0.03% |
| Durata media del management | 1.8yrs |
| Durata media del Consiglio di amministrazione | 4.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 09J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹6b |
| Jun 30 2024 | n/a | n/a | ₹6b |
| Mar 31 2024 | ₹71m | ₹35m | ₹6b |
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹65m | ₹37m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹59m | ₹18m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹5b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹32m | ₹7m | ₹4b |
Compensazione vs Mercato: La retribuzione totale di Nikhil ($USD 846.14K ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 611.10K ).
Compensazione vs guadagni: La retribuzione di Nikhil è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Nikhil Chopra (51 yo)
3.9yrs
Mandato
₹71,338,000
Compensazione
Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.9yrs | ₹71.34m | 0.026% ₹ 69.9m | |
| Assistant Vice President – Human Resource | no data | ₹10.48m | 0.0025% ₹ 6.7m | |
| Chief Financial Officer | less than a year | ₹12.74m | Nessun dato | |
| President of Operations | no data | ₹28.44m | Nessun dato | |
| Vice President of Finance & Accounts | no data | ₹9.48m | Nessun dato | |
| Vice President of Information & Technology | 9.8yrs | ₹10.70m | Nessun dato | |
| Vice President of HR & Administration | 8.2yrs | ₹13.80m | 0.00084% ₹ 2.3m | |
| Vice President of Legal | 1.8yrs | ₹11.49m | Nessun dato | |
| President of Global Business | no data | ₹42.09m | 0.012% ₹ 31.5m | |
| Executive Vice President of Operations of Daman | 1.3yrs | ₹17.24m | 0.0048% ₹ 13.1m | |
| Executive Vice President of Supply Chain Operations | no data | ₹19.54m | 0.0084% ₹ 22.7m | |
| Executive Vice President | less than a year | ₹18.12m | 0.0032% ₹ 8.7m |
1.8yrs
Durata media
51yo
Età media
Gestione esperta: Il team dirigenziale di JBCHEPHARM non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Whole-Time Director | 4.1yrs | ₹71.34m | 0.026% ₹ 69.9m | |
| Chairman of Biotech Laboratories (Pty ) Ltd | no data | Nessun dato | Nessun dato | |
| Non-Executive Independent Chairman | less than a year | Nessun dato | Nessun dato | |
| Non-Executive & Independent Director | 4.3yrs | ₹7.50m | Nessun dato | |
| Non-Executive Director | 4.3yrs | Nessun dato | Nessun dato | |
| Non-Executive & Non-Independent Director | less than a year | Nessun dato | Nessun dato | |
| Non-Executive Director | 3.8yrs | Nessun dato | Nessun dato | |
| Non-Executive & Independent Director | 4.3yrs | ₹7.50m | Nessun dato |
4.1yrs
Durata media
64.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di JBCHEPHARM sono considerati esperti (durata media dell'incarico 4.1 anni).